SEPTInvestingStart Free

SYRE SCHEDULE 13G/A: SEC filing

An amendment to a Schedule 13G was

Filed with the SEC on · accession 0001493215-26-000157

SYRE filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. An amendment to a Schedule 13G was filed regarding Spyre Therapeutics, Inc., indicating a change in a passive institutional holder's ownership position. The stock moved +1.7% by the first close after the filing.

Summary of the filing

An amendment to a Schedule 13G was filed regarding Spyre Therapeutics, Inc., indicating a change in a passive institutional holder's ownership position. The filing text provided contains only the EDGAR directory listing and no substantive ownership details.

For details, click here →

Key details

IssuerSpyre Therapeutics, Inc.

How SYRE stock reacted

Close before

$101.85

Aug 13, 2026

First close after

+1.75%

$103.63

5 trading days

+5.83%

$107.79

Since filing

+1.97%

$103.86

✦ Ask GOAX AI about this filing — what it means for SYRE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for SYRE?

Click here

Frequently asked questions

What did SYRE file with the SEC on Aug 14, 2026?

SYRE filed a SCHEDULE 13G/A (SEC filing). An amendment to a Schedule 13G was filed regarding Spyre Therapeutics, Inc., indicating a change in a passive institutional holder's ownership position. The filing text provided contains only the EDGAR directory listing and no substantive ownership details.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did SYRE stock react to this filing?

SYRE closed at $101.85 before the filing and $103.63 on Aug 14, 2026 (+1.75%). Five trading days later: $107.79 (+5.83%).

Other SYRE SEC filings

Get alerts when SYRE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
SYRE overviewSYRE analysisSYRE newsLatest SEC filings